Descriptive data for patients with FTD, DLB and AD
| FTD (n=12) | DLB (n=10) | AD (n=9) | p Value | |
| Sex ratio | ||||
| Male/female | 8/4 | 6/4 | 6/3 | NS |
| Age at onset of dementia | ||||
| Median | 65.5 | 77.0 | 73.0 | 0.035 |
| Mean (SD) | 65.5 (9.5) | 75.0 (9.1) | 72.0 (9.2) | |
| Age at time of FP-CIT SPECT | ||||
| Median | 70.0 | 81.5 | 77.0 | 0.028 |
| Mean (SD) | 69.3 (9.5) | 77.9 (8.4) | 76.2 (7.3) | |
| Years of education | ||||
| Median | 9.0 | 9.0 | 9.0 | NS |
| Mean (SD) | 10.3 (2.4) | 9.3 (1.3) | 10.1 (1.8) | |
| Past psychiatric history | ||||
| Yes/no | 1/11 | 0/10 | 2/7 | NS |
| SSRI at scan | ||||
| Yes/no | 8/4 | 0/9 | 0/9 | 0.000 |
p Value <0.05.
AD, Alzheimer's disease; DLB, dementia with Lewy bodies; FP-CIT, [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane; FTD, frontotemporal dementia; NS, non-significant; SSRI, selective serotonin reuptake inhibitor.